2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33273056 | An Anti-CD22-seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models. | 2021 Feb | 1 |
| 2 | 28829594 | CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells. | 2017 Sep 13 | 1 |